Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in gestational diabetes
NCT00572689Phase 4Withdrawn
- Sponsor
- Georgetown University
- Start
- Aug 2013
- Primary completion
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in gestational diabetes mellitus (GDM), sponsored by Georgetown University. Planned start Aug 2013; status: withdrawn.
02
Drugs
exenatide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT00572689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572689.